{
    "clinical_study": {
        "@rank": "111140", 
        "arm_group": [
            {
                "arm_group_label": "Lupeol", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients are supposed to apply lupeol on one side of face two times per day for 8 weeks"
            }, 
            {
                "arm_group_label": "Control vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients are supposed to apply vehicle control to another side of face two times per day for 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "For the chemical lupeol isolated from eggplant, we applied it to one side of face, and\n      applied vehicle control to another side for 8 -weeks. The study was performed in a 8-week,\n      randomized controlled, split face fashion. Investigators evaluated safety and efficacy\n      during baseline, 2 weeks, 4weeks, and 8 weeks after beginning of study."
        }, 
        "brief_title": "Clinical Trial of Lupeol for Mild-moderate Acne", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Acne", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over the age 15 who were clinically diagnosed with mild to moderate acne\n             vulgaris\n\n        Exclusion Criteria:\n\n          -  ; known pregnancy or lactation, any medical illness that might influence the results\n             of the study, a previous history of oral acne medication or surgical procedures\n             including laser treatment within 6 month and topical medication within 4 weeks of\n             study enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02152865", 
            "org_study_id": "anti-acne product"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lupeol", 
                "description": "Patients are supposed to apply lupeol cream to one side of their face two times per day for 8 weeks.", 
                "intervention_name": "Lupeol", 
                "intervention_type": "Drug", 
                "other_name": "no brand name"
            }, 
            {
                "arm_group_label": "Control vehicle", 
                "description": "Patients are supposed to apply their control vehicle to the other side of their face for 8 weeks", 
                "intervention_name": "Control vehicle", 
                "intervention_type": "Drug", 
                "other_name": "No brand name"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lupeol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "medication", 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Seoul National University Institutional Review Board, Seoul: Korea"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Both inflammatory & non-inflammatory acne lesions of both of their facial sides", 
            "measure": "Acne lesion counts as a measure of efficacy", 
            "safety_issue": "No", 
            "time_frame": "8 weeks after beginning of applications"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02152865"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Dae Hun Suh", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Among total patients enrolled in this study, number of patients either experiencing objective adverse events or subjective uncomfortableness  were counted", 
            "measure": "Number of Participants with Adverse Events as a Measure of Safety and Tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks after beggning of applications"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}